Deutsche Bank Ag\ Ultragenyx Pharmaceutical Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,688,971 shares of RARE stock, worth $75.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,688,971

Previous 1,782,340 5.24%

Holding current value

$75.6 Million

Previous $73.3 Million 28.08%

% of portfolio

0.04%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.21 - $59.36 $3.75 Million - $5.54 Million	-93,369 Reduced 5.24%	1,688,971 $93.8 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $21.5 Million - $29.7 Million	575,115 Added 47.64%	1,782,340 $73.3 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $1.48 Million - $1.84 Million	34,359 Added 2.93%	1,207,225 $56.4 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $7.14 Million - $11.1 Million	225,134 Added 23.76%	1,172,866 $56.1 Million
Q3 2023 Nov 09, 2023	BUY	$34.92 - $46.66 $2.1 Million - $2.8 Million	60,001 Added 6.76%	947,732 $33.8 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $18,301 - $25,553	-490 Reduced 0.06%	887,731 $41 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $981,788 - $1.29 Million	26,542 Added 3.08%	888,221 $35.6 Million
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $1.08 Million - $1.48 Million	32,012 Added 3.86%	861,679 $39.9 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $13.7 Million - $22.6 Million	341,959 Added 70.12%	829,667 $34.4 Million
Q2 2022 Aug 11, 2022	BUY	$45.8 - $85.4 $5.6 Million - $10.4 Million	122,180 Added 33.43%	487,708 $29.1 Million
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $5.59 Million - $7.58 Million	-89,805 Reduced 19.72%	365,528 $26.5 Million
Q4 2021 Feb 11, 2022	BUY	$73.71 - $87.86 $7.34 Million - $8.75 Million	99,547 Added 27.98%	455,333 $38.3 Million
Q3 2021 Nov 04, 2021	SELL	$77.92 - $102.4 $1.8 Million - $2.36 Million	-23,095 Reduced 6.1%	355,786 $32.1 Million
Q2 2021 Aug 11, 2021	SELL	$92.19 - $115.71 $4.42 Million - $5.55 Million	-47,965 Reduced 11.24%	378,881 $36.1 Million
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $3.57 Million - $5.6 Million	-33,358 Reduced 7.25%	426,846 $48.6 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $2.39 Million - $5.03 Million	28,343 Added 6.56%	460,204 $63.7 Million
Q3 2020 Nov 12, 2020	SELL	$72.98 - $90.0 $3.62 Million - $4.46 Million	-49,607 Reduced 10.3%	431,861 $35.5 Million
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $310,075 - $517,034	6,610 Added 1.39%	481,468 $37.7 Million
Q1 2020 May 14, 2020	BUY	$33.8 - $62.9 $1.25 Million - $2.33 Million	36,989 Added 8.45%	474,858 $21.1 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $884,248 - $1.12 Million	-24,508 Reduced 5.3%	437,869 $18.7 Million
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $3.72 Million - $5.53 Million	-87,618 Reduced 15.93%	462,377 $19.8 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $5.42 Million - $7.34 Million	98,699 Added 21.87%	549,995 $34.9 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $10.5 Million - $18.3 Million	264,422 Added 141.5%	451,296 $31.3 Million
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $4.3 Million - $8.56 Million	-110,679 Reduced 37.2%	186,874 $8.12 Million
Q3 2018 Dec 21, 2021	BUY	$71.81 - $90.15 $4.75 Million - $5.97 Million	66,187 Added 28.61%	297,553 $22.7 Million
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $6.87 Million - $8.62 Million	-95,654 Reduced 29.25%	231,366 $17.7 Million
Q2 2018 Apr 21, 2020	BUY	$48.54 - $85.31 $1.19 Million - $2.1 Million	24,606 Added 8.14%	327,020 $25.1 Million
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $3 Million - $5.27 Million	-61,755 Reduced 16.96%	302,414 $23.2 Million
Q1 2018 Oct 18, 2019	BUY	$44.33 - $58.52 $3.74 Million - $4.94 Million	84,423 Added 30.18%	364,169 $18.6 Million
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $4.26 Million - $5.62 Million	96,069 Added 52.3%	279,746 $14.3 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $7.77 Million - $10.2 Million	-178,443 Reduced 49.28%	183,677 $8.52 Million
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $18 Million - $24 Million	362,120	362,120 $19.3 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account